Singapore markets open in 7 hours 25 minutes

CRISPR Therapeutics AG (CRSP)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
55.96-0.45 (-0.80%)
As of 01:34PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts18182321
Avg. Estimate-1.29-1.54-5.62-4.23
Low estimate-1.84-1.86-7.48-7.95
High estimate0.8-1.02-2.635.08
Year ago EPS-0.67-0.98-1.94-5.62
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts17172323
Avg. Estimate28.11M9.88M115.03M406.2M
Low estimateN/AN/A15M40M
High estimate202.55M43.7M457.9M3.31B
Year ago sales100M70M371.21M115.03M
Sales growth (year/est)-71.90%-85.90%-69.00%253.10%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-1.7-2.12-1.95-0.07
Actual EPS-0.67-0.98-1.411.1
Difference1.031.140.541.17
Surprise %60.60%53.80%27.70%1,671.40%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-1.29-1.54-5.62-4.23
7 days ago-1.42-1.53-5.68-4.27
30 days ago-1.41-1.52-5.68-4.27
60 days ago-1.35-1.56-5.67-4.22
90 days ago-1.62-1.7-5.52-3.69
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 days1111
Up last 30 days1111
Down last 7 daysN/AN/AN/AN/A
Down last 30 days11N/A1
Growth estimatesCRSPIndustrySector(s)S&P 500
Current qtr.-92.50%N/AN/AN/A
Next qtr.-57.10%N/AN/AN/A
Current year-189.70%N/AN/AN/A
Next year24.70%N/AN/AN/A
Next 5 years (per annum)-200.40%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A